Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy

Annals of Surgical Oncology

Volumn 12, Issue 2, 2005, Pages 138-144

  Alexander Jr , H Richard ^a   Libutti, Steven K ^a   Pingpank, James F ^a   Bartlett, David L ^a   Helsabeck, Cynthia ^a   Beresneva, Tatiana ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Isolated hepatic perfusion; Liver metastases; Melphalan Hyperthermia; Metastatic colorectal cancer

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MELPHALAN; OXALIPLATIN;

ADULT; AGE DISTRIBUTION; AGED; ARTERY OCCLUSION; AXILLARY VEIN; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CANNULA; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; EXTRACORPOREAL OXYGENATION; FEMALE; GASTRODUODENAL ARTERY; HEPATIC ARTERY; HOSPITALIZATION; HUMAN; IMAGING; INFERIOR CAVA VEIN; LAPAROTOMY; LIVER METASTASIS; LIVER PERFUSION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN; RADIOGRAPHY; REVIEW; SEX ROLE; TEMPERATURE; TREATMENT FAILURE; TUMOR GROWTH;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LIVER NEOPLASMS; MALE; MELPHALAN; MIDDLE AGED; NEOPLASM STAGING; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 16844367586     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2005.05.003     Document Type: Review

References (21)

1. A Jemal T Murray A Samuels 2003 Cancer statistics, 2003 CA Cancer J Clin. 53 5 26
2. D Gorog A Toth J Weltner 1997 Prognosis of untreated liver metastasis from rectal cancer Acta Chir Hung. 36 106 7
3. LB Saltz JV Cox C Blanke 2000 Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer N Engl J Med. 343 905 14
4. JY Douillard D Cunningham AD Roth 2000 Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Lancet 355 1041 7
5. A de Gramont A Figer M Seymour 2000 Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer J Clin Oncol. 18 2938 47
6. H Hurwitz L Fehrenbacher T Cartwright 2003 Bevacizumab (a monoclonal antibody to vascular endothelial growth factor) prolongs survival in first-line colorectal cancer (CRC): results of a phase III trial of bevacizumab in combination with bolus IFL (irinotecan, 5-fluorouracil, leucovorin) as first-line therapy in subjects with metastatic CRC (abstract) Proc Am Soc Clin Oncol. 22 906
7. NE Kemeny D Niedzwiecki DR Hollis 2003 Hepatic arterial infusion (HAI) versus systemic therapy for hepatic metastases from colorectal cancer: a CALGB randomized trial of efficacy, quality of life (QOL), cost effectiveness, and molecular markers (abstract) Proc Am Soc Clin Oncol. 22 252
8. MC Rothenberg AM Oza RH Bigelow 2003 Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial J Clin Oncol. 21 2059 69
9. N Kemeny M Gonen D Sullivan 2001 Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer J Clin Oncol. 19 2687 95
10. C Fordy C Glover MM Davies TG Allen-Mersh 1998 Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases Br J Cancer 78 1058 60
11. HR Alexander DL Bartlett SK Libutti 1998 Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver J Clin Oncol. 16 1479 89
12. DL Bartlett SK Libutti WD Figg 2001 Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer Surgery 129 176 87
13. HR Alexander SK Libutti JF Pingpank 2003 Hyperthermic isolated hepatic perfusion (IHP) using melphalan for patients with ocular melanoma metastatic to liver Clin Cancer Res. 9 6343 9
14. KJ Oldhafer H Lang M Frerker 1998 First experience and technical aspects of isolated liver perfusion for extensive liver metastasis Surgery 123 622 31
15. SK Libutti DL Bartlett DL Fraker HR Alexander 2000 Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies J Am Coll Surg. 191 519 30
16. LB Saltz JV Cox C Blanke 2000 Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group N Engl J Med. 343 905 14
17. TE Lans DL Bartlett SK Libutti 2001 Role of tumor necrosis factor (TNF) on toxicity and cytokine production following isolated hepatic perfusion (IHP) Clin Cancer Res. 7 784 90
18. G Fiorentini S Rossi P Dentico 2004 Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study Anticancer Res. 24 2093 6
19. N Kemeny F Fata 2001 Hepatic-arterial chemotherapy Lancet Oncol. 2 418 28
20. LM Ellis JL Chase YZ Patt SA Curley 2000 Hepatic arterial infusion chemotherapy for colorectal cancer metastasis to the liver JA Curley Liver Cancer Springer-Verlag New York 150 72
21. JF Pingpank SK Libutti R Chang 2003 A phase I feasibility study of hepatic arterial melphalan infusion with hepatic arterial melphalan infusion with hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies (abstract) Proc Am Soc Clin Oncol. 22 282